H-1B sponsorship profile: TCR2 Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, TCR2 Therapeutics Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (5 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on TCR2 Therapeutics Inc’s H-1B petitions range from $76,300 at the low end to $90,000 at the high end, with a petition-weighted average of $85,740. That range reflects the mix of occupations the company sponsors, led by Senior Research Associate, T Cell Process Development (2 petitions at $86,549 avg), followed by Sr. QA Associate and Senior Research Associate, T Cell Process Development . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. TCR2 Therapeutics Inc is headquartered in Cambridge, MA under NAICS code 541715, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where TCR2 Therapeutics Inc ranks. By H-1B petition volume, TCR2 Therapeutics Inc is #26,547 of 119,880 employers nationally and #1,208 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.